Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Non-Current Debt (2013 - 2015)

Inogen (INGN) reported Non-Current Debt of $80000.0 for Q3 2015, down 79.54% year-over-year from $391000.0 in Q3 2014, and down 49.69% on a QoQ basis from $159000.0 in Q2 2015.

Inogen (INGN) has 3 years of Non-Current Debt data on file, last reported at $80000.0 in Q3 2015.

  • Quarterly Non-Current Debt fell 79.54% year-over-year to $80000.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $80000.0 (down 79.54% YoY) and the FY2014 annual result came in at $315000.0, down 94.16% from the prior year.
  • Non-Current Debt fell to $80000.0 in Q3 2015 per INGN's latest filing, from $159000.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $6.3 million in Q2 2014 and bottomed at $80000.0 in Q3 2015.
  • The 3-year median for Non-Current Debt is $353000.0 (2014), against an average of $2.1 million.
  • Peak annual rise in Non-Current Debt reached 79.54% in 2015, while the deepest fall reached 97.49% in 2015.
  • Tracing INGN's Non-Current Debt over 3 years: stood at $5.4 million in 2013, then slumped by 94.16% to $315000.0 in 2014, then tumbled by 74.6% to $80000.0 in 2015.
  • Per Business Quant, the three latest INGN Non-Current Debt figures stand at $80000.0 (Q3 2015), $159000.0 (Q2 2015), and $237000.0 (Q1 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 29.64 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.22 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 27.88 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.81 Bn
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2015 80,000.00
Sep 30, 2015 80,000.00
Jun 30, 2015 159,000.00
Jun 30, 2015 159,000.00
Mar 31, 2015 237,000.00
Mar 31, 2015 237,000.00
Dec 31, 2014 315,000.00
Dec 31, 2014 315,000.00
Sep 30, 2014 391,000.00
Sep 30, 2014 391,000.00
Jun 30, 2014 6.33 Mn
Jun 30, 2014 6.33 Mn
Mar 31, 2014 4.15 Mn
Mar 31, 2014 4.15 Mn
Dec 31, 2013 5.39 Mn
Dec 31, 2013 5.39 Mn